Virtu Financial’s Cellectis CLLS Stock Holding History

Virtu Financial’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25,211	Closed	-$72K	–	1742
2025 Q3	$72K	Buy	+25,211	New	+$65.3K	﹤0.01%	1084
2022 Q3	–	Sell	-16,366	Closed	-$46K	–	1783
2022 Q2	$46K	Buy	+16,366	New	+$57.6K	﹤0.01%	1144

Other funds holding CLLS

BGI

B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu Financial's CLLS Position: Q4 2025 in Review

Virtu Financial sold out of Cellectis (CLLS) in Q4 2025, closing a stake of 25,211 shares — an estimated $72K sold.

Virtu Financial first reported a position in CLLS in Q2 2022 and held it in 2 quarters. The position peaked at $72K in Q3 2025. 34 funds tracked by Wall St. Rank hold CLLS as of Q4 2025.

Virtu Financial reported no remaining Cellectis position as of Q4 2025 after selling out during the quarter.
Virtu Financial sold 25,211 Cellectis shares in Q4 2025, an estimated $72K.
Virtu Financial first reported a position in Cellectis in Q2 2022 and held it in 2 quarters.
Virtu Financial's Cellectis position peaked at $72K in Q3 2025.
34 funds tracked by Wall St. Rank held Cellectis as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.